Literature DB >> 9417874

Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.

S Wu1, Z P Zhang, D Zhang, D R Soprano, K J Soprano.   

Abstract

We wished to determine the effect of altering the levels or functional activity of retinoid receptors, in particular retinoic acid receptor-alpha (RAR-alpha) and retinoid X receptor-alpha (RXR-alpha) on the growth sensitivity of ovarian tumor cells to all-trans-retinoic acid (all-trans-RA). We found that CA-OV3 cells could be made resistant to all-trans-RA growth inhibition by overexpressing RAR-beta(R269Q), an efficient dominant negative mutant which inhibits the function of all RAR subtypes. Antisense technology was then used to prepare stable transfectants of the retinoid-sensitive ovarian carcinoma cell line CA-OV3 in which expression of RAR-alpha, RXR-alpha, or both RAR-alpha and RXR-alpha was reduced. The effect of all-trans-RA on ovarian tumor cell growth was determined by MTT assay, autoradiographic analysis of DNA synthesis, and anchorage-independent colony formation in soft agar. Our results show that cell lines expressing reduced levels of either RAR-alpha alone or RXR-alpha alone exhibited a small decrease in sensitivity to growth inhibition by all-trans-RA. However, maximum RA resistance was obtained in cell lines in which the levels of both RAR-alpha and RXR-alpha were reduced. These results demonstrate the importance of both retinoid nuclear receptors and retinoid-X receptors in general, and RAR-alpha and RXR-alpha in particular, as mediators of ovarian carcinoma cell growth inhibition by retinoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9417874     DOI: 10.1006/excr.1997.3769

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Synergistic effects of 8-Cl-cAMP and retinoic acids in the inhibition of growth and induction of apoptosis in ovarian cancer cells: induction of retinoic acid receptor beta.

Authors:  R K Srivastava; A R Srivastave; Y S Cho-Chung
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

2.  Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.

Authors:  C D Katsetos; I Stadnicka; J C Boyd; H Ehya; S Zheng; C M Soprano; H S Cooper; A S Patchefsky; D R Soprano; K J Soprano
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

3.  N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.

Authors:  Rajiv Janardhanan; Jonathan T Butler; Naren L Banik; Swapan K Ray
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

4.  N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cells.

Authors:  Rajiv Janardhanan; Naren L Banik; Swapan K Ray
Journal:  Cancer Lett       Date:  2008-03-08       Impact factor: 8.679

5.  Vitamin A metabolism is impaired in human ovarian cancer.

Authors:  Stephen J Williams; Dusica Cvetkovic; Thomas C Hamilton
Journal:  Gynecol Oncol       Date:  2008-12-25       Impact factor: 5.482

Review 6.  Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids.

Authors:  Petr Chlapek; Viera Slavikova; Pavel Mazanek; Jaroslav Sterba; Renata Veselska
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.